产品简要
公司名称 :
安迪生物R&D
产品类型 :
蛋白
产品名称 :
重组人类IL-6R甲蛋白
目录 :
227-SR
规格 :
25微克
价格 :
379美元
更多信息或购买 :
文章摘录数: 38
参考文献
Findeisen M, Allen T, Henstridge D, Kammoun H, Brandon A, Baggio L, et al. Treatment of type 2 diabetes with the designer cytokine IC7Fc. Nature. 2019;574:63-68 pubmed 出版商
Aryappalli P, Shabbiri K, Masad R, Al Marri R, Haneefa S, Mohamed Y, et al. Inhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and Lung Cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 Receptor. Int J Mol Sci. 2019;20: pubmed 出版商
McGregor N, Murat M, Elango J, Poulton I, Walker E, Crimeen Irwin B, et al. IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis. J Biol Chem. 2019;294:7850-7863 pubmed 出版商
Yamamoto S, Omori K, Mandai H, Nakayama M, Nakagawa S, Kobayashi H, et al. Fungal metabolite (+)-terrein suppresses IL-6/sIL-6R-induced CSF1 secretion by inhibiting JAK1 phosphorylation in human gingival fibroblasts. Heliyon. 2018;4:e00979 pubmed 出版商
Tanaka Y, Sabharwal L, Ota M, Nakagawa I, Jiang J, Arima Y, et al. Presenilin 1 Regulates NF-?B Activation via Association with Breakpoint Cluster Region and Casein Kinase II. J Immunol. 2018;: pubmed 出版商
Lyman M, Lieuw V, Richardson R, Timmer A, Stewart C, Granger S, et al. A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases. J Biol Chem. 2018;293:9326-9334 pubmed 出版商
Huang R, Sun Y, Ho C, Liu K, Tang Q, Xie Y, et al. IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways. Cell Death Dis. 2018;9:144 pubmed 出版商
Alsaffar H, Martino N, Garrett J, Adam A. Interleukin-6 promotes a sustained loss of endothelial barrier function via Janus kinase-mediated STAT3 phosphorylation and de novo protein synthesis. Am J Physiol Cell Physiol. 2018;314:C589-C602 pubmed 出版商
Ravi A, Plumb J, Gaskell R, Mason S, Broome C, Booth G, et al. COPD monocytes demonstrate impaired migratory ability. Respir Res. 2017;18:90 pubmed 出版商
Larsen J, Petersen C. SorLA in Interleukin-6 Signaling and Turnover. Mol Cell Biol. 2017;37: pubmed 出版商
Wang J, Qiao C, Xiao H, Lin Z, Li Y, Zhang J, et al. Structure-based virtual screening and characterization of a novel IL-6 antagonistic compound from synthetic compound database. Drug Des Devel Ther. 2016;10:4091-4100 pubmed 出版商
Bastidas Coral A, Bakker A, Zandieh Doulabi B, Kleverlaan C, Bravenboer N, Forouzanfar T, et al. Cytokines TNF-α, IL-6, IL-17F, and IL-4 Differentially Affect Osteogenic Differentiation of Human Adipose Stem Cells. Stem Cells Int. 2016;2016:1318256 pubmed 出版商
Lee J, Kim J, Kim B, Han H, Kang S, Cho N. STAT3-induced WDR1 overexpression promotes breast cancer cell migration. Cell Signal. 2016;28:1753-60 pubmed 出版商
Harwardt T, Lukas S, Zenger M, Reitberger T, Danzer D, Übner T, et al. Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like Response. PLoS Pathog. 2016;12:e1005748 pubmed 出版商
Zhong H, Davis A, Ouzounova M, Carrasco R, Chen C, Breen S, et al. A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors. Cancer Res. 2016;76:480-90 pubmed 出版商
Bhardwaj R, Yester J, Singh S, Biswas D, Surace M, Waters M, et al. RelB/p50 complexes regulate cytokine-induced YKL-40 expression. J Immunol. 2015;194:2862-70 pubmed 出版商
Isobe A, Sawada K, Kinose Y, Ohyagi Hara C, Nakatsuka E, Makino H, et al. Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer. PLoS ONE. 2015;10:e0118080 pubmed 出版商
Sobotta M, Liou W, Stöcker S, Talwar D, Oehler M, Ruppert T, et al. Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. Nat Chem Biol. 2015;11:64-70 pubmed 出版商
Bu Y, Su F, Wang X, Gao H, Lei L, Chang N, et al. Protein tyrosine phosphatase PTPN9 regulates erythroid cell development through STAT3 dephosphorylation in zebrafish. J Cell Sci. 2014;127:2761-70 pubmed 出版商
Shaw S, Bourne T, Meier C, Carrington B, Gelinas R, Henry A, et al. Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling. MAbs. 2014;6:774-82 pubmed 出版商
O Reilly S, Ciechomska M, Cant R, van Laar J. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-? (TGF-?) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem. 2014;289:9952-60 pubmed 出版商
McFarland B, Hong S, Rajbhandari R, Twitty G, Gray G, Yu H, et al. NF-?B-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma. PLoS ONE. 2013;8:e78728 pubmed 出版商
Csaszar E, Wang W, Usenko T, Qiao W, Delaney C, Bernstein I, et al. Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling. Blood. 2014;123:650-8 pubmed 出版商
Zheng Y, McFarland B, Drygin D, Yu H, Bellis S, Kim H, et al. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma. Clin Cancer Res. 2013;19:6484-94 pubmed 出版商
Yoo H, Seo J, Yoo J. CTR9, a component of PAF complex, controls elongation block at the c-Fos locus via signal-dependent regulation of chromatin-bound NELF dissociation. PLoS ONE. 2013;8:e61055 pubmed 出版商
Patel A, Zhu Y, Kuzhikandathil E, Banks W, Siegel A, Zalcman S. Soluble interleukin-6 receptor induces motor stereotypies and co-localizes with gp130 in regions linked to cortico-striato-thalamo-cortical circuits. PLoS ONE. 2012;7:e41623 pubmed 出版商
Narazaki M, Segarra M, Hou X, Tanaka T, Li X, Tosato G. Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. Blood. 2010;116:3099-107 pubmed 出版商
Umehara A, Nishioka M, Obata T, Ebina Y, Shiota H, Hashida S. A novel ultra-sensitive enzyme immunoassay for soluble human insulin receptor ectodomain and its measurement in urine from healthy subjects and patients with diabetes mellitus. Clin Biochem. 2009;42:1468-75 pubmed 出版商
Yammani R, Long D, Loeser R. Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes. Arthritis Rheum. 2009;60:792-800 pubmed 出版商
Ara T, Song L, Shimada H, Keshelava N, Russell H, Metelitsa L, et al. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. Cancer Res. 2009;69:329-37 pubmed 出版商
Ahmed S, Marotte H, Kwan K, Ruth J, Campbell P, Rabquer B, et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc Natl Acad Sci U S A. 2008;105:14692-7 pubmed 出版商
Patterson S, Reid S, Gray S, Nimmo M. The response of plasma interleukin-6 and its soluble receptors to exercise in the cold in humans. J Sports Sci. 2008;26:927-33 pubmed 出版商
Kino T, Boos T, Sulima A, Siegel E, Gold P, Rice K, et al. 3-O-Formyl-20R,21-epoxyresibufogenin suppresses IL-6-type cytokine actions by targeting the glycoprotein 130 subunit: potential clinical implications. J Allergy Clin Immunol. 2007;120:437-44 pubmed
Ammit A, Moir L, Oliver B, Hughes J, Alkhouri H, Ge Q, et al. Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2007;292:L199-206 pubmed
Mozaffarian D, Rimm E, King I, Lawler R, McDonald G, Levy W. trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr. 2004;80:1521-5 pubmed
Bas S, Gauthier B, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol. 2004;172:4470-9 pubmed
Hurst S, McLoughlin R, Monslow J, Owens S, Morgan L, Fuller G, et al. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J Immunol. 2002;169:5244-51 pubmed
Erices A, Conget P, Rojas C, Minguell J. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Exp Cell Res. 2002;280:24-32 pubmed
产品信息
品牌 :
R&D Systems
master code :
227-SR
SKU号 :
227-SR-025
产品名称 :
重组人类IL-6R甲蛋白
描述 :
The Recombinant Human IL-6R alpha Protein from R&D Systems is derived from Sf 21 (baculovirus). The Recombinant Human IL-6R alpha Protein has been validated for the following applications: Bioactivity.
靶标 :
IL-6R甲
类别 :
蛋白和酶
单位尺寸 :
25微克
缓冲液 :
Lyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein.
共轭标签 :
未共轭
纯度 :
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
物种 :
人类
观察到的分子量 :
45-50 kDa, reducing conditions
理论上的分子量 :
38 kDa
基因符号 :
IL6R
功能细节 :
Measured by its ability to enhance the IL-6 activity on M1 mouse myeloid leukemia cells. Saito, T. et al . (1991) J. Immunol. 147 :168. The ED50 for this effect is 5.0-15.0 ng/mL.
内毒素说明 :
<1.0 EU per 1 µg of the protein by the LAL method.
catalog number base :
227-SR
accessionNumbers :
P08887.1
应用 :
Bioactivity
来源 :
Spodoptera frugiperda , Sf 21 (baculovirus)-derived human IL-6R alpha protein Leu20-Asp358
2020美元 :
379
2021美元 :
379美元
别名 :
CD126, gp80, IL-6 R甲, IL6Q, IL6R, IL6R甲, IL-6R-1, IL6RA, IL-6RA, IL6RQ, 白细胞介素-6受体
储存 :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
更多信息或购买 :
公司信息
安迪生物R&D
上海市长宁区延安西路726号华敏翰尊国际大厦24A1
info@rndsystemschina.com.cn
http://www.rndsystemschina.com.cn
21 52380373
公司总部: 美国
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.